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A 16 kDa buckwheat protein (BWp16) is a major allergen responsible for
immediate hypersensitivity reactions including anaphylaxis. A deletion mutant
of BWp16 (rBWp16N) was overproduced and puriﬁed and was shown to be
immunologically active. A three-wavelength MAD data set was collected from a
crystal of selenomethionine-labelled rBWp16N. The crystal belonged to the
triclinicspacegroupP1,withunit-cellparametersa=28.39,b=31.54,c=32.20 A ˚ ,
  = 111.92,   = 108.91,   = 98.74 . One monomer was expected to be present
in the asymmetric unit based on the calculated Matthews coefﬁcient of
1.76 A ˚ 3 Da
 1.
1. Introduction
Buckwheat (Fagopyrum esculentum) belongs to the Polygonaceae
family. Buckwheat noodles are a popular food in East Asian coun-
tries. Buckwheat-ﬂour productsarealso becoming popularin Western
countries as a healthy food with a high protein content. However,
some people exhibit hypersensitivity mediated by an antibody IgE
speciﬁc to buckwheat proteins (Wieslander, 1996; Horesh, 1972).
Ingestion of a small amount of buckwheat can cause immediate
hypersensitivity reactions, termed anaphylaxis. This hypersensitivity
often starts in childhood and continues throughout life, in contrast to
allergies to other foods such as cow’s milk (Takahashi et al., 1998).
Investigators have reported that 24, 19, 16, 14, 10 and 9 kDa
buckwheat proteins can react with IgE antibodies from allergic
patients (Nagata et al., 2000; Park et al., 2000; Tanaka et al., 2002;
Yoshimasu et al., 2000; Matsumoto et al., 2004). Most of these
investigations were performed using nonheated and non-pepsin-
digested buckwheat extracts. However, the foods that we consume
are usually cooked and are digested by proteolytic enzymes such as
pepsin in our bodies. Tanaka and coworkers demonstrated that the
16 kDa buckwheat protein BWp16, a member of the 2S albumin
family (Shewry et al., 1995), was resistant to pepsin and preserved its
reactivity with IgE antibodies from allergic patients with immediate
hypersensitivity reactions (Tanaka et al., 2002). In contrast, the other
candidates were digested by pepsin and the resulting fragments lost
their reactivity with IgE antibodies. Thus, BWp16 is a strong candi-
date as the major buckwheat allergen responsible for immediate
hypersensitivity reactions including anaphylaxis.
The epitopes recognized by IgE antibodies are divided into two
types: a linear epitope in which the key residues arise from a linear
amino-acid sequence and a structural epitope in which the key resi-
dues arise from widely different positions in the linear amino-acid
sequence. As mentioned above, IgE antibodies might recognize the
structural epitopes of BWp16 because of its pepsin resistance. To
investigate the molecular mechanism of buckwheat allergy at an
atomic level, it is important to determine the structural epitopes of
the major buckwheat allergen BWp16. Therefore, we attempted the
structural characterization of recombinant BWp16 (rBWp16) and
its N-terminal deletion mutant (rBWp16N), which appears to beimmunologically equivalent to BWp16. Here, we describe the
puriﬁcation, crystallization and preliminary X-ray analysis of
rBWp16N.
2. Materials and methods
2.1. Cloning, expression and purification
rBWp16 was prepared as described previously (Koyano etal., 2006)
and further puriﬁed using a prepacked anion-exchange column with a
bed volume of 1 ml (HiTrap Q FF, GE Healthcare). rBWp16N was
overproduced in Escherichia coli as a soluble protein with a gluta-
thione S-transferase (GST) tag at its N-terminus. The gene encoding
residues 13–127 was ampliﬁed using the forward primer 50-CGT-
GGATCCCTGGTTCCGCGTGGAAGCTCAAAGTGCATGCGA-
30 and the reverse primer 50-CGGCTCGAGTTACACAAAATAC-
CGATTTCCTCT-30. [The underlined sequences denote introduced
BamHI and XhoI sites, respectively, and the italicized sequence
denotes a thrombin recognition site. The codon AGC (shown in bold
in the forward primer) for the last amino acid (Ser) of the thrombin
recognition site overlapped with that for the 13th amino acid of
BWp16 (Ser13).] The resulting fragment was cut and cloned into
pGEX-6P-2 (GE Healthcare) vector. rBWp16N consisted of resi-
dues 13–127 of BWp16 and the N-terminal vector-derived Gly
residue left after removal of the GST tag by thrombin cleavage. The
constructed plasmid was then transformed into E. coli strain Origami
B (DE3) (Novagen). The cells were grown at 310 K in Luria–Bertani
(LB) medium. When the optical density of the medium reached 0.4 at
600 nm, isopropyl  -d-1-thiogalactopyranoside was added to a ﬁnal
concentration of 0.4 mM. Cultivation was continued for 4 h at 298 K.
The cells were resuspended in phosphate-buffered saline (PBS) and
then sonicated. The soluble fraction was passed through a 0.22 mm
syringe ﬁlter and then bound to 5 ml of Glutathione-Sepharose
FF (GE Healthcare) in an open column. The bound protein was
exhaustively washed with PBS and eluted with 50 mM Tris–HCl pH
8.0 containing 10 mM reduced  -glutathione. The GST-fusion protein
was digested by thrombin and dialyzed against PBS at 293 K. To
remove the digested GST tag, the digested protein was again applied
onto the above-mentioned open column. The ﬂowthrough fraction
was dialyzed against 20 mM Tris–HCl pH 8.5 and loaded onto
MonoQ HR10/10 (GE Healthcare) equilibrated with the same buffer.
The bound rBWp16N was eluted with a linear gradient (20 mM
increase per column volume) of sodium chloride (NaCl) at a ﬂow rate
of 2.0 ml min
 1. Selenomethionine (SeMet)-labelled protein was
overproduced in E. coli strain B834 (DE3) (Novagen). It was
prepared by the same procedure as described above except for the
use of LeMaster medium (LeMaster & Richards, 1985) instead of LB
medium.
2.2. Enzyme-linked immunosorbent assay (ELISA)
After coating 96-well plates (Nunc LockWell Module Plate, Nunc)
with rBWp16 or rBWp16N (1.0 mg per 50 mlo f5 0 m M sodium
carbonate buffer pH 9.6 in the well) and incubating overnight at
277 K, they were washed with PBS containing 0.05% Tween 20
(PBS-T) and blocked with 0.1% casein-PBS for 1 h at room tem-
perature. These plates were then washed again with PBS-T and
incubated overnight at 277 K with serum samples diluted to 5% (1:20
dilution) in 0.1% casein-PBS. The wells were washed four times with
PBS-T containing 1.0 M NaCl. They were then exposed to horse-
radish peroxidase (HRP) conjugated goat anti-human IgE antibodies
(Nordic Immunology, 1:1000 dilution) in 0.1% casein-PBS for 1 h at
room temperature. The bound antibodies were reacted with a sub-
strate solution (TMB reagent, BD Biosciences). The colorimetric
intensity at 450 nm was measured according to the manufacturer’s
protocol.
2.3. Crystallization
Initial screening for crystallization was performed by the hanging-
drop vapour-diffusion method at 293 K. The protein solution was
adjusted to 15 mg ml
 1 (1.1 mM)i n1 0m M MES pH 6.5 containing
10 mM NaCl. Each hanging drop was prepared by mixing 0.7 ml each
of the protein solution and the reservoir solution and was equili-
brated against 0.5 ml of the latter. Commercially available kits
manufactured by Emerald BioSystems and Hampton Research were
used for initial crystallization screening and a total of approximately
400 conditions were tried. The identiﬁed conditions were then opti-
mized by replacing the buffer and/or the precipitant and by changing
the concentrations of the precipitant, buffer and additive.
2.4. Data collection and processing
Crystals were mounted in cryoloops (Hampton Research) and
cryoprotected by soaking them brieﬂy in mother liquor containing
20%(w/v) 2-methyl-2,4-pentanediol before ﬂash-freezing in a stream
of nitrogen gas at 95 K. Native and three-wavelength MAD data sets
were collected on beamline BL6A at the Photon Factory using a
Quantum 4R detector (Area Detector Systems Corporation). The
MAD experiment wavelengths were determined from an XAFS
experiment on an SeMet-labelled rBWp16N crystal. The diffraction
data were indexed, integrated and scaled using MOSFLM (Powell,
1999) and SCALA (Collaborative Computational Project, Number 4,
1994) as implemented in XIA2 (http://www.ccp4.ac.uk/xia/). An
anomalous difference Patterson map for the peak data set
(  = 0.9786 A ˚ ) was calculated using FFT (Read & Schierbeek, 1988)
and contoured sections were drawn using MAPSLICER (Winn et al.,
2002).
3. Results and discussion
A homology search of BWp16 within the Protein Data Bank showed
that BWp16 had sequence similarity to 2S albumins or related
proteins from peanut (PDB code 1w2q; 30% identity; Lehmann et al.,
2006), castor bean (PDB code 1psy; 27% identity; Pantoja-Uceda et
al., 2003) and oilseed rape (PDB code 1sm7; 23% identity; Pantoja-
Uceda et al., 2004). These structures were determined by NMR
spectroscopy; no crystal structures of 2S albumins were available. The
N-terminal regions of the 2S albumins from peanut and castor bean
were highly disordered. We therefore prepared an N-terminal dele-
tion mutant BWp16N as the N-terminal region of BWp16 was
predicted to be ﬂexible by analogy with the 2S albumins. rBWp16N
was expressed as a GST-fusion protein in E. coli and was puriﬁed to
apparent homogeneity, yielding approximately 1.5 mg of protein per
litre of medium.
To clarify whether rBWp16N could react with IgE antibodies
from an allergic patient, we performed ELISA. The IgE-binding
activity of serum from a buckwheat-allergic patient to rBWp16N
was comparable with that to rBWp16. The colorimetric intensities
measured at 450 nm were 0.168   0.024 and 0.161   0.028 for
rBWp16 and rBWp16N, respectively. rBWp16 was shown to be
immunologically equivalent to the wild-type BWp16 (Koyano et al.,
2006). These results indicate that rBWp16N possesses allergenicity
and that the 12 N-terminal residues are not necessary for IgE binding.
After trials of approximately 400 conditions in the initial screening,
an rBWp16N crystal was obtained under condition No. 40 of the
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phosphate–citrate pH 4.2, 5%(w/v) PEG 1000]. However, we did not
succeed in crystallizing rBWp16. Therefore, the deletion of the 12
N-terminal residues was likely to affect crystallization. Crystallization
conditions were optimized for rBWp16N and the following two
promising conditions were established. One is a slight modiﬁcation of
Cryo I condition No. 40 [36%(v/v) ethanol, 0.1 M phosphate–citrate
pH 4.2, 1%(w/v) PEG 1000; condition I]. The other was 29%(v/v)
1-propanol, 0.1 M phosphate–citrate pH 4.2, 1%(w/v) PEG 1000
(condition II). Plate-like crystals grew within 2 d and reached a
maximum dimension of 0.2 mm (Fig. 1a); dissolution occurred within
several days under both conditions. A complete data set was collected
to 1.72 A ˚ resolution from a native crystal obtained under condition I.
Table 1 gives a summary of the data-collection and data-processing
statistics. The native crystal belonged to the monoclinic space group
P21, with unit-cell parameters a = 27.92, b = 58.54, c = 32.16 A ˚ ,
  = 109.34 . The calculated Matthews coefﬁcient of 1.87 A ˚ 3 Da
 1
(Matthews, 1968), corresponding to a solvent content of 34%, indi-
cated the presence of one monomer in the asymmetric unit.
We ﬁrst attempted to solve the structure of rBWp16N using
molecular-replacement (MR) techniques. Three homology models
crystallization communications
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Figure 1
Crystals of rBWp16N( a) and its SeMet derivative (b). The scale bars correspond
to 0.1 mm. The crystals in (a) and (b) were obtained under conditions I and II,
respectively.
Table 1
Data-collection and processing statistics.
Values in parentheses are for the highest resolution shell.
SeMet derivative
Data set Native Peak Edge Remote
Experimental conditions
Beamline BL6A BL6A
Wavelength (A ˚ ) 0.9780 0.9786 0.9791 0.9639
Temperature (K) 95 95
Detector ADSC Quantum 4R ADSC Quantum 4R
Oscillation angle (  per frame) 1.0 1.0 1.0 1.0
Exposure time (s per frame) 30.0 30.0 30.0 30.0
No. of images 180 360 300 172
Intensity statistics
Space group P21 P1
Unit-cell parameters (A ˚ ,  ) a = 27.92, b = 58.54, c = 32.16,   = 109.34 a = 28.39, b = 31.54, c = 32.20,   = 111.92,   = 108.91,   = 98.74
Software used MOSFLM MOSFLM
Resolution range (A ˚ ) 30.34–1.72 (1.76–1.72) 27.81–1.60 (1.64–1.60) 27.22–1.60 (1.64–1.60) 27.21–1.60 (1.64–1.60)
Rmerge† (%) 4.0 (24.8) 4.0 (11.9) 3.6 (13.7) 8.6 (33.1)
Completeness (%) 99.7 (100.0) 88.0 (87.1) 88.1 (88.2) 87.1 (87.3)
I/ (I) 12.2 (3.0) 12.8 (6.1) 14.8 (5.4) 6.8 (2.3)
Multiplicity 3.6 (3.6) 3.8 (3.8) 3.2 (3.2) 1.8 (1.9)
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of the ith observation and hI(hkl)i is the mean intensity of the reﬂections.
Figure 2
A section at w = 0.317 of the anomalous difference Patterson map for the SeMet
derivative containing the highest peak. The map was calculated using the peak data
and is contoured at intervals of 0.5  starting at 3.0  above the mean density level.were constructed based on the above-mentioned protein structures
using MODELLER (Sali & Blundell, 1993) and were used as search
models. However, no signiﬁcant peaks were found in the rotation and
translation functions despite exhaustive attempts and the calculated
phases from the MR solutions did not give any interpretable electron
density. Therefore, we prepared SeMet-labelled rBWp16N and
crystallized it for MAD structure determination. The puriﬁed protein
yield decreased to 0.1 mg per litre of medium for derivatization.
SeMet-labelled rBWp16N crystals were grown under conditions I
and II. Fig. 1(b) shows SeMet-labelled rBWp16N crystals obtained
under condition II. In the XAFS experiment a clear selenium
absorption edge was monitored from a crystal, enabling us to deter-
mine the peak (0.9786 A ˚ ), edge (0.9791 A ˚ ) and remote (0.9639 A ˚ )
wavelengths. A three-wavelength MAD data set was collected to
1.60 A ˚ resolution from a crystal obtained under condition II. The
crystal belonged to the triclinic space group P1, with unit-cell para-
meters a = 28.39, b = 31.54, c = 32.20 A ˚ ,   = 111.92,   = 108.91,
  = 98.74 . One monomer was expected to be present in the unit cell
based on the calculated Matthews coefﬁcient of 1.76 A ˚ 3 Da
 1
(Matthews, 1968), corresponding to a solvent content of 30%. Table 1
shows a summary of the data-collection and data-processing statistics.
The peak data set showed strong peaks derived from Se atoms in an
anomalous difference Patterson map contoured at 3.0  above the
mean density level. A section of the map containing the highest peak
is shown in Fig. 2. Phasing calculations using SOLVE (Terwilliger &
Berendzen, 1999) are now in progress.
Synchrotron-radiation experiments were performed at the Photon
Factory with the approval of the Photon Factory Advisory
Committee, the National Laboratory for High Energy Accelerator
Research Organization, Japan (Proposal No. 2007G617) and at
SPring-8 with the approval of the Japan Synchrotron Radiation
Research Institute (Proposal No. 2008A1221).
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